Paper9104819
CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion.
Wu Y and 4 others. J Exp Med, 1997. Cited by 83 papers, by iCite.
Cite this record
ConductScience Library. CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion. Papers, record 9104819. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9104819
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Differentiation | Major topic |
| B7-1 Antigen | Major topic |
| CD28 Antigens | Major topic |
| Immunoconjugates | Major topic |
| Lymphocyte Activation | Major topic |
| T-Lymphocytes | Major topic |
| Abatacept | |
| Animals | |
| Antigens, CD | |
| CHO Cells | |
| CTLA-4 Antigen | |
| Cricetinae | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Mutant Strains | |
| Mutation | |
| Protein Binding | |
| Recombinant Fusion Proteins |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA058033 | NCI NIH HHS | United States | R01CA058033 | PubMed and NIH | NIH RePORTER |
| CA69016 | NCI NIH HHS | United States | PubMed | PubMed | |
| CA58033 | NCI NIH HHS | United States | R01CA058033 | PubMed and NIH | NIH RePORTER |
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7481803 | Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. | Science | 1995 | https://conductscience.org/library/papers/7481803 | PubMed |
| 2 | 9064355 | Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. | J Exp Med | 1996 | https://conductscience.org/library/papers/9064355 | PubMed |
| 3 | 8574588 | Rapid induction of a novel costimulatory activity on B cells by CD40 ligand. | Curr Biol | 1995 | https://conductscience.org/library/papers/8574588 | PubMed |
| 4 | 8596936 | Enhancement of antitumor immunity by CTLA-4 blockade. | Science | 1996 | https://conductscience.org/library/papers/8596936 | PubMed |
| 5 | 4194660 | A theory of self-nonself discrimination. | Science | 1970 | https://conductscience.org/library/papers/4194660 | PubMed |
| 6 | 3159820 | Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen). | J Exp Med | 1985 | https://conductscience.org/library/papers/3159820 | PubMed |
| 7 | 3875683 | Involvement of T44 molecules in an antigen-independent pathway of T cell activation. Analysis of the correlations to the T cell antigen-receptor complex. | J Exp Med | 1985 | https://conductscience.org/library/papers/3875683 | PubMed |
| 8 | 6443557 | Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. | Annu Rev Immunol | 1983 | https://conductscience.org/library/papers/6443557 | PubMed |
| 9 | 2950524 | Identification of a monoclonal antibody specific for a murine T3 polypeptide. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/2950524 | PubMed |
| 10 | 2825196 | Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/2825196 | PubMed |
| 11 | 2830495 | T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. | Mol Cell Biol | 1987 | https://conductscience.org/library/papers/2830495 | PubMed |
| 12 | 2653373 | Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. | Annu Rev Immunol | 1989 | https://conductscience.org/library/papers/2653373 | PubMed |
| 13 | 2567241 | A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines. | Eur J Immunol | 1989 | https://conductscience.org/library/papers/2567241 | PubMed |
| 14 | 2185332 | The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. | J Exp Med | 1990 | https://conductscience.org/library/papers/2185332 | PubMed |
| 15 | 2164219 | T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2164219 | PubMed |
| 16 | 1847722 | Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. | J Exp Med | 1991 | https://conductscience.org/library/papers/1847722 | PubMed |
| 17 | 1714933 | CTLA-4 is a second receptor for the B cell activation antigen B7. | J Exp Med | 1991 | https://conductscience.org/library/papers/1714933 | PubMed |
| 18 | 1717561 | CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. | J Immunol | 1991 | https://conductscience.org/library/papers/1717561 | PubMed |
| 19 | 1346270 | Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. | J Exp Med | 1992 | https://conductscience.org/library/papers/1346270 | PubMed |
| 20 | 1313950 | CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. | Nature | 1992 | https://conductscience.org/library/papers/1313950 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40943370 | Enhancing Antitumor Efficacy of MUC1 mRNA Nano-Vaccine by CTLA-4 siRNA-Mediated Immune Checkpoint Modulation in Triple Negative Breast Cancer Mice Model. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943370 | PubMed |
| 40516913 | Deciphering molecular pathways in urological cancers: A gateway to precision therapeutics. | J Adv Res | 2026 | https://conductscience.org/library/papers/40516913 | PubMed |
| 37366922 | Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma. | Curr Oncol | 2023 | https://conductscience.org/library/papers/37366922 | PubMed |
| 36857433 | Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4- and PD-1-targeted immunotherapy. | Sci Transl Med | 2023 | https://conductscience.org/library/papers/36857433 | PubMed |
| 36309492 | Differential trafficking of ligands trogocytosed via CD28 versus CTLA4 promotes collective cellular control of co-stimulation. | Nat Commun | 2022 | https://conductscience.org/library/papers/36309492 | PubMed |
| 34176099 | Targeting the extracellular matrix for immunomodulation: applications in drug delivery and cell therapies. | Drug Deliv Transl Res | 2021 | https://conductscience.org/library/papers/34176099 | PubMed |
| 32408880 | Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges. | J Nanobiotechnology | 2020 | https://conductscience.org/library/papers/32408880 | PubMed |
| 32286179 | Insights into CD8 T Cell Activation and Exhaustion from a Mouse Gammaherpesvirus Model. | Viral Immunol | 2020 | https://conductscience.org/library/papers/32286179 | PubMed |
| 31836191 | Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy. | Trends Pharmacol Sci | 2020 | https://conductscience.org/library/papers/31836191 | PubMed |
| 29472691 | A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy. | Cell Res | 2018 | https://conductscience.org/library/papers/29472691 | PubMed |
| 25383875 | Limited density of an antigen presented by RMA-S cells requires B7-1/CD28 signaling to enhance T-cell immunity at the effector phase. | PLoS One | 2014 | https://conductscience.org/library/papers/25383875 | PubMed |
| 22337882 | Ligation of cytotoxic T lymphocyte antigen-4 to T cell receptor inhibits T cell activation and directs differentiation into Foxp3+ regulatory T cells. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22337882 | PubMed |
| 19326996 | CD28/B7-mediated co-stimulation is critical for early control of murine cytomegalovirus infection. | Viral Immunol | 2009 | https://conductscience.org/library/papers/19326996 | PubMed |
| 19089435 | Cytotoxic T lymphocyte antigen-4 promoter -658CT gene polymorphism is associated with ulcerative colitis in Chinese patients. | Int J Colorectal Dis | 2009 | https://conductscience.org/library/papers/19089435 | PubMed |
| 18776148 | Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. | Endocr Rev | 2008 | https://conductscience.org/library/papers/18776148 | PubMed |
| 18205702 | T regulatory cells: aid or hindrance in the clearance of disease? | J Cell Mol Med | 2007 | https://conductscience.org/library/papers/18205702 | PubMed |
| 17369021 | The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. | J Autoimmun | 2007 | https://conductscience.org/library/papers/17369021 | PubMed |
| 16940527 | CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68. | J Virol | 2006 | https://conductscience.org/library/papers/16940527 | PubMed |
| 16896154 | CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. | Blood | 2006 | https://conductscience.org/library/papers/16896154 | PubMed |
| 11560959 | Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. | J Clin Invest | 2001 | https://conductscience.org/library/papers/11560959 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD28 | 940 | PubTator's text mining | https://conductscience.org/library/genes/940 | NCBI Gene |
| CD80 | 941 | PubTator's text mining | https://conductscience.org/library/genes/941 | NCBI Gene |
| CD86 | 942 | PubTator's text mining | https://conductscience.org/library/genes/942 | NCBI Gene |
| CTLA4 | 1493 | PubTator's text mining | https://conductscience.org/library/genes/1493 | NCBI Gene |
| HHLA2 | 11148 | PubTator's text mining | https://conductscience.org/library/genes/11148 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9104819
GET https://conductscience.org/api/papers/v1/9104819/references?page=2